These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 14991920)

  • 1. Synthesis of tumor-associated glycopeptide antigens for the development of tumor-selective vaccines.
    Dziadek S; Kunz H
    Chem Rec; 2004; 3(6):308-21. PubMed ID: 14991920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomimetic synthesis of the tumor-associated (2,3)-sialyl-T antigen and its incorporation into glycopeptide antigens from the mucins MUC1 and MUC4.
    Dziadek S; Brocke C; Kunz H
    Chemistry; 2004 Sep; 10(17):4150-62. PubMed ID: 15352098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic glycopeptides for the development of tumour-selective vaccines.
    Kunz H
    J Pept Sci; 2003 Sep; 9(9):563-73. PubMed ID: 14552419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.
    Sørensen AL; Reis CA; Tarp MA; Mandel U; Ramachandran K; Sankaranarayanan V; Schwientek T; Graham R; Taylor-Papadimitriou J; Hollingsworth MA; Burchell J; Clausen H
    Glycobiology; 2006 Feb; 16(2):96-107. PubMed ID: 16207894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution-phase synthesis with solid-state workup of an O-glycopeptide with a cluster of cancer-related T antigens.
    Shao N; Guo Z
    Org Lett; 2005 Aug; 7(16):3589-92. PubMed ID: 16048349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell recognition of tumor-associated carbohydrates: the nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity.
    Galli-Stampino L; Meinjohanns E; Frische K; Meldal M; Jensen T; Werdelin O; Mouritsen S
    Cancer Res; 1997 Aug; 57(15):3214-22. PubMed ID: 9242452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of tumor-associated glycopeptide antigens.
    Brocke C; Kunz H
    Bioorg Med Chem; 2002 Oct; 10(10):3085-112. PubMed ID: 12150854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The (2-phenyl-2-trimethylsilyl)ethyl-(PTMSEL)-linker in the synthesis of glycopeptide partial structures of complex cell surface glycoproteins.
    Wagner M; Dziadek S; Kunz H
    Chemistry; 2003 Dec; 9(24):6018-30. PubMed ID: 14679514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic glycopeptides for the development of cancer vaccines.
    Liakatos A; Kunz H
    Curr Opin Mol Ther; 2007 Feb; 9(1):35-44. PubMed ID: 17330400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry.
    Cai H; Huang ZH; Shi L; Zhao YF; Kunz H; Li YM
    Chemistry; 2011 May; 17(23):6396-406. PubMed ID: 21538615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple column synthesis of a library of T-cell stimulating Tn-antigenic glycopeptide analogues for the molecular characterization of T-cell-glycan specificity.
    Frische K; Meldal M; Werdelin O; Mouritsen S; Jensen T; Galli-Stampino L; Bock K
    J Pept Sci; 1996; 2(4):212-22. PubMed ID: 9231328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic vaccine consisting of a tumor-associated sialyl-T(N)-MUC1 tandem-repeat glycopeptide and tetanus toxoid: induction of a strong and highly selective immune response.
    Kaiser A; Gaidzik N; Westerlind U; Kowalczyk D; Hobel A; Schmitt E; Kunz H
    Angew Chem Int Ed Engl; 2009; 48(41):7551-5. PubMed ID: 19685547
    [No Abstract]   [Full Text] [Related]  

  • 13. Formation of lactones from sialylated MUC1 glycopeptides.
    Pudelko M; Lindgren A; Tengel T; Reis CA; Elofsson M; Kihlberg J
    Org Biomol Chem; 2006 Feb; 4(4):713-20. PubMed ID: 16467946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and immunological evaluation of an antitumor neoglycopeptide vaccine bearing a novel homoserine Tn antigen.
    Vichier-Guerre S; Lo-Man R; Huteau V; Dériaud E; Leclerc C; Bay S
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3567-70. PubMed ID: 15177475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of tumor associated sialyl-T-glycopeptides and their immunogenicity.
    Komba S; Werdelin O; Jensen T; Meldal M
    J Pept Sci; 2000 Dec; 6(12):585-93. PubMed ID: 11192238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of selected LeY and KH-1 analogues: a medicinal chemistry approach to vaccine optimization.
    Spassova MK; Bornmann WG; Ragupathi G; Sukenick G; Livingston PO; Danishefsky SJ
    J Org Chem; 2005 Apr; 70(9):3383-95. PubMed ID: 15844973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective synthesis of sialylated tumor-associated glycosylamino acids.
    Corcilius L; Payne RJ
    Org Lett; 2013 Nov; 15(22):5794-7. PubMed ID: 24160308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fully synthetic self-adjuvanting thioether-conjugated glycopeptide-lipopeptide antitumor vaccines for the induction of complement-dependent cytotoxicity against tumor cells.
    Cai H; Sun ZY; Huang ZH; Shi L; Zhao YF; Kunz H; Li YM
    Chemistry; 2013 Feb; 19(6):1962-70. PubMed ID: 23280874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards a fully synthetic carbohydrate-based anticancer vaccine: synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated tn antigen.
    Buskas T; Ingale S; Boons GJ
    Angew Chem Int Ed Engl; 2005 Sep; 44(37):5985-8. PubMed ID: 16108081
    [No Abstract]   [Full Text] [Related]  

  • 20. Oligosaccharide-peptide ligation of glycosyl thiolates with dehydropeptides: synthesis of S-linked mucin-related glycopeptide conjugates.
    Galonić DP; Van Der Donk WA; Gin DY
    Chemistry; 2003 Dec; 9(24):5997-6006. PubMed ID: 14679512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.